» Ind-Swift Chalks Out Ambitious Over $ 20 Million Expansion Plan » Ind-Swift Laboratories Limited undergoes successful USFDA audit » Ind-Swift files DMF for Donepezil Hydrochloride and Nateglinide Ind-Swift files DMF for Venlafaxine Hydrochloride and Pioglitazone Hydrochloridend Ind Swift Labs Ltd. has recently filed two DMFs with USFDA for Venlafaxine Hydrochloride and Pioglitazone Hydrochloride. The company had filed DMF for Clarithromycin in 2003. Ind Swift is planning to file 4 more DMFs by end of this year.